BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25157992)

  • 1. The effects of neoadjuvant chemotherapy on resectability of locally-advanced gastric adenocarcinoma: a clinical trial.
    Hashemzadeh S; Pourzand A; Somi MH; Zarrintan S; Javad-Rashid R; Esfahani A
    Int J Surg; 2014 Oct; 12(10):1061-9. PubMed ID: 25157992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma.
    Alexander HR; Grem JL; Pass HI; Hamilton M; McAtee N; Fraker DL; Allegra CJ
    Oncology (Williston Park); 1993 May; 7(5):37-42; discussion 42-4, 49-50, 53. PubMed ID: 8512781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer.
    Morant R
    Onkologie; 2001 Apr; 24(2):116-21. PubMed ID: 11441289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Nowak K; Kieser M; Slanger TE; Burmeister B; Kelsen D; Niedzwiecki D; Schuhmacher C; Urba S; van de Velde C; Walsh TN; Ychou M; Jensen K
    Eur J Surg Oncol; 2017 Aug; 43(8):1550-1558. PubMed ID: 28551325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer.
    Téoule P; Trojan J; Bechstein W; Woeste G
    Dig Surg; 2015; 32(4):229-37. PubMed ID: 25966823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
    Schuhmacher C; Gretschel S; Lordick F; Reichardt P; Hohenberger W; Eisenberger CF; Haag C; Mauer ME; Hasan B; Welch J; Ott K; Hoelscher A; Schneider PM; Bechstein W; Wilke H; Lutz MP; Nordlinger B; Van Cutsem E; Siewert JR; Schlag PM
    J Clin Oncol; 2010 Dec; 28(35):5210-8. PubMed ID: 21060024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
    Bösing NM; Heise JW; Röher HD
    Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer.
    Marcus SG; Cohen D; Lin K; Wong K; Thompson S; Rothberger A; Potmesil M; Hiotis S; Newman E
    J Gastrointest Surg; 2003 Dec; 7(8):1015-22; discussion 1023. PubMed ID: 14675711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy in locally advanced gastric cancer: what to avoid. Preliminary analysis of a consecutive series of patients.
    Rausei S; Lianos GD; Proserpio I; Ruspi L; Galli F; Frattini F; Mangano A; Rovera F; Boni L; Roukos DH; Pinotti G; Dionigi G
    Tumori; 2015; 101(5):511-6. PubMed ID: 25908036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
    Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U
    Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial.
    Zheng Y; Yang X; Yan C; Feng R; Sah BK; Yang Z; Zhu Z; Liu W; Xu W; Ni Z; Beeharry MK; Hua Z; Yan M; Zhu Z; Li C
    Eur J Cancer; 2020 May; 130():12-19. PubMed ID: 32171104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic neoadjuvant chemotherapy in locally advanced gastric carcinoma: phase II study with 5-fluorouracil, epirubicin and etoposide].
    Catania G; Puleo C; Catalano F; Altadonna V; Scilletta S; Migliore M; Iuppa A; Cardì F
    Chir Ital; 2000; 52(4):385-91. PubMed ID: 11190529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
    Schulz C; Kullmann F; Kunzmann V; Fuchs M; Geissler M; Vehling-Kaiser U; Stauder H; Wein A; Al-Batran SE; Kubin T; Schäfer C; Stintzing S; Giessen C; Modest DP; Ridwelski K; Heinemann V
    Int J Cancer; 2015 Aug; 137(3):678-85. PubMed ID: 25530271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
    Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
    Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.
    Hartgrink HH; van de Velde CJ; Putter H; Songun I; Tesselaar ME; Kranenbarg EK; de Vries JE; Wils JA; van der Bijl J; van Krieken JH;
    Eur J Surg Oncol; 2004 Aug; 30(6):643-9. PubMed ID: 15256239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
    Glatz T; Bronsert P; Schäfer M; Kulemann B; Marjanovic G; Sick O; Hopt UT; Zirlik K; Makowiec F; Hoeppner J
    Eur J Surg Oncol; 2015 Oct; 41(10):1300-7. PubMed ID: 26253194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemotherapy of locally advanced gastric cancer.
    Rougier P; Lasser P; Ducreux M; Mahjoubi M; Bognel C; Elias D
    Ann Oncol; 1994; 5 Suppl 3():59-68. PubMed ID: 8204531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.